Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients

Susanne Ghandili, Susanne Pfefferle, Kevin Roedl, Piet Sonnemann, Panagiotis Karagiannis, Olaf Boenisch, Stefan Kluge, Stefan Schmiedel, Harald Ittrich, Holger Rohde, Marc Lütgehetmann, Katja Weisel (+5 others)
2020 Blood Advances  
Key Points Patients with acute leukemia present with a prolonged and severe course of COVID-19, which is paralleled by high rates of viremia. Low-intensive chemotherapy seems to be more feasible in patients with acute myeloid leukemia and concomitant SARS-CoV-2 infection.
doi:10.1182/bloodadvances.2020002543 pmid:33275765 fatcat:d2hyi5jkgzdmjgexkthwtufssu